Vice President, Business Development and Licensing
Recursion · New York, New York
CHECKED 1H AGO
Bio & Science AIonsiteVP
At a glance
Highlights
- Lead licensing and co-development deals for first-in-class clinical assets.
- Drive deals validating an AI-native platform spanning biology and chemistry.
- Partner daily with biology, clinical, CMC and data science teams.
Ideal candidate
Seasoned biopharma dealmaker with deep oncology networks who thrives leading complex negotiations and collaborating across science and business to advance AI-enabled drug discovery.
Requirements
- BS/BA in life sciences (biology, chemistry, pharmacy, medical)
- Advanced degree (JD, MBA, PhD, PharmD) strongly preferred
- 12-15+ years in biotech/pharma with focus on oncology and I&I
- 7+ years direct business development and licensing with buy-side and sell-side track record
- Strong network of senior relationships across biotech and large pharma
- Deep knowledge of drug development from discovery through commercialization
- Track record leading complex negotiations and closing high-value transactions
- Demonstrated interest in AI-enabled drug discovery
- remote policy
- Flexibility to work remotely as needed
Lab profile
About Recursion
AI-native biotech industrializing drug discovery with automation and data to advance oncology and rare disease medicines.
What they build
- Recursion OS drug discovery platform
- Oncology clinical pipeline
- Rare disease clinical pipeline
Known for
- AI-native end-to-end drug discovery
- Computational biology for early discovery
- Clinical development in oncology and rare disease
Key facts
- Founded 2013
- Headquartered in Salt Lake City, Utah
- Public company (Nasdaq: RXRX)